| |
T2DM
|
Non-T2DM
|
Both
|
|---|
|
OR (95% CI)
|
p-value
|
OR (95% CI)
|
p-value
|
OR (95% CI)
|
p-value
|
|---|
|
Age
|
1.03 (1.01–1.05)
|
0.013
|
1.02 (1.01–1.03)
|
0.003
|
1.02 (1.01–1.03)
|
0.002
|
|
Female sex
|
1.03 (0.73–1.44)
|
0.677
|
1.27 (1.08–1.49)
|
0.009
|
1.21 (1.04–1.39)
|
0.008
|
|
Coronary artery bypass graft
|
1.54 (1.07–2.21)
|
0.020
|
1.74 (1.45–2.08)
|
< 0.001
|
1.71 (1.45–2.00)
|
< 0.001
|
|
Intra-aortic balloon counter-pulsation
|
9.64 (5.60–16.58)
|
< 0.001
|
9.21 (7.01–12.09)
|
< 0.001
|
9.46 (7.41–12.06)
|
< 0.001
|
|
Pacemaker implantation
|
0.39 (0.16–0.90)
|
0.029
|
0.46 (0.32–0.67)
|
< 0.001
|
0.44 (0.32–0.62)
|
< 0.001
|
|
Blood transfusion
|
NS
|
NS
|
1.36 (1.16–1.60)
|
< 0.001
|
1.36 (1.18–1.58)
|
< 0.001
|
|
Acute renal disease
|
3.67 (2.56–5.28)
|
< 0.001
|
3.01 (2.54–3.57)
|
< 0.001
|
3.00 (2.57–3.50)
|
< 0.001
|
|
Congestive heart failure
|
2.30 (1.65–3.22)
|
< 0.001
|
1.82 (1.56–2.13)
|
< 0.001
|
1.89 (1.64–2.18)
|
< 0.001
|
|
Atrial fibrillation
|
0.66 (0.48–0.93)
|
0.017
|
0.59 (0.50–0.68)
|
< 0.001
|
0.59 (0.52–0.68)
|
< 0.001
|
|
Pulmonary hypertension
|
NS
|
NS
|
0.83 (0.70–0.98)
|
0.031
|
0.84 (0.72–0.99)
|
0.034
|
|
Obesity
|
NS
|
NS
|
0.54 (0.36–0.82)
|
0.004
|
0.66 (0.48–0.91)
|
0.011
|
|
Endocarditis
|
NS
|
NS
|
1.49 (1.25–1.79)
|
< 0.001
|
1.49 (1.27–1.75)
|
< 0.001
|
|
Pneumonia
|
2.91 (1.33–6.37)
|
0.007
|
2.96 (2.19–4.03)
|
< 0.001
|
3.00 (2.26–3.99)
|
< 0.001
|
|
Renal disease
|
1.61 (1.05–2.46)
|
0.029
|
NS
|
NS
|
1.27 (1.04–1.56)
|
0.021
|
|
Liver disease
|
2.58 (1.29–5.17)
|
0.007
|
3.22 (2.36–4.40)
|
< 0.001
|
3.09 (2.33–4.11)
|
< 0.001
|
|
Year
|
0.95 (0.91–0.99)
|
0.018
|
0.93 (0.92–0.95)
|
< 0.001
|
0.93 (0.92–0.95)
|
< 0.001
|
|
T2DM
|
NS
|
NS
|
NS
|
NS
|
0.88 (0.74–1.05)
|
0.172
|
- T2DM type 2 diabetes mellitus, NS not significant
